Literature DB >> 15641481

Facing erectile dysfunction due to prostate cancer treatment: perspectives of men and their partners.

Ulrike Boehmer1, Richard K Babayan.   

Abstract

A well-known side effect of prostate cancer treatment is erectile dysfunction. However, little is known about how men and their sexual partners think about the threat of erectile dysfunction prior to prostate cancer treatment. Twenty-one patients who had been diagnosed with early prostate cancer, but not yet treated, and 13 female partners of these men were recruited from two urologists' offices. In separate, semistructured individual interviews with men and their partners, thoughts about the threat of erectile dysfunction were solicited. Men's reactions to the possibility of losing their sexual capacity due to prostate cancer-related treatment were linked to their current level of sexual function. Women reacted to erectile dysfunction by stressing the existence of other relationship dimensions, whereas they were aware about the gravity of their male partners' feelings about potency. Finally, both men and women alike had concerns about the implications of erectile dysfunction on their relationship. Physicians advising men about treatment options should consider exploring men's current sexual function, thoughts about identity, and especially men's relationship situation. Physicians addressing these issues with men and their partners should provide resources for counseling.

Entities:  

Mesh:

Year:  2004        PMID: 15641481     DOI: 10.1081/cnv-200039641

Source DB:  PubMed          Journal:  Cancer Invest        ISSN: 0735-7907            Impact factor:   2.176


  9 in total

Review 1.  Prostate cancer and the impact on couples: a qualitative metasynthesis.

Authors:  Nicole Collaço; Carol Rivas; Lauren Matheson; Johana Nayoan; Richard Wagland; Obrey Alexis; Anna Gavin; Adam Glaser; Eila Watson
Journal:  Support Care Cancer       Date:  2018-03-06       Impact factor: 3.603

2.  [Sexuality of couples 5 years after radical prostatectomy. Sexuality of patients and their partners 1 year postoperatively in sexually active couples].

Authors:  T B Jordan; R Ernst; G Hatzichristodoulou; A Dinkel; T Klorek; C Beyrle; J E Gschwend; K Herkommer
Journal:  Urologe A       Date:  2015-10       Impact factor: 0.639

3.  [Sexual intercourse following radical nerve-sparing prostatectomy: discrepancies between patients and their female partners].

Authors:  C Mücke; G Hatzichristodoulou; J E Gschwend; K Herkommer
Journal:  Urologe A       Date:  2011-02       Impact factor: 0.639

Review 4.  Eroticization as a factor influencing erectile dysfunction treatment effectiveness.

Authors:  K C Kukula; R A Jackowich; R J Wassersug
Journal:  Int J Impot Res       Date:  2013-07-04       Impact factor: 2.896

Review 5.  Management of complications of androgen deprivation therapy in the older man.

Authors:  Supriya G Mohile; Karen Mustian; Kathryn Bylow; William Hall; William Dale
Journal:  Crit Rev Oncol Hematol       Date:  2008-10-25       Impact factor: 6.312

Review 6.  The top 13: what family physicians should know about prostate cancer.

Authors:  Anne Katz; Alan Katz
Journal:  Can Fam Physician       Date:  2008-02       Impact factor: 3.275

7.  A brief couples' workshop for improving sexual experiences after prostate cancer treatment: a feasibility study.

Authors:  Amy J D Hampton; Lauren M Walker; Andrea Beck; John W Robinson
Journal:  Support Care Cancer       Date:  2013-08-10       Impact factor: 3.603

8.  The influence of developmental life stage on quality of life in survivors of prostate cancer and their partners.

Authors:  Janet Harden; Laurel Northouse; Bernadine Cimprich; Joanne M Pohl; Jersey Liang; Trace Kershaw
Journal:  J Cancer Surviv       Date:  2008-03-14       Impact factor: 4.442

9.  Using the Framework Method for the Analysis of Qualitative Dyadic Data in Health Research.

Authors:  Nicole Collaço; Richard Wagland; Obrey Alexis; Anna Gavin; Adam Glaser; Eila K Watson
Journal:  Qual Health Res       Date:  2021-05-13
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.